glp-1 kidney stones Can GLP‑1 medications increase stone risk? A UAB urologist offers insight Kidney Stones: Types, Causes, Risk

Transcriptional adaptation of Shigella flexneri during infection of macrophages and epithelial cells: insights into the strategies of a cytosolic bacterial pathogen

While there are plenty of wins, many women do experience worsening hyperpigmentation around this time, too

The IGF1-binding site is formed by the L1 and CR domains (CRD) of one IGF1R protomer, and the -CT and FnIII-1 domains of the other

Hematopoietic stem cell transplantation for neurological disorders: A focus on inborn errors of metabolism

Bacteriostatic Water is listed as a laboratory reagent containing 0.9% benzyl alcohol for research handling workflows

The critical difference between a drug on the 503B list and an FDA-approved medication is the level of scrutiny, he continued